• Boracay Hotels
• Cebu Hotels
• Free Articles Submissions

Bali Hotels

Web Related Articles

• Targeted Breast Cancer Drug Shrinks Tumors

A new targeted cancer drug called T-DM1 has been shown to shrink tumors in women with metastatic breast cancer after an average of seven other drugs, including Herceptin, failed....

• Experimental Drug Shrinks Breast Tumors

An experimental drug can slash the number of chemotherapy-resistant cancer stem cells in women with advanced breast cancer, curbing tumor growth, researchers report....

• Skin Cancer Drug Erivedge Approved

The FDA has approved Erivedge, a once-daily pill that can shrink disfiguring or metastatic basal cell carcinoma (BCC) tumors....

• Breast Cancer Treated by Freezing Tumors

In a small but promising study, researchers were able to kill breast cancer tumors by freezing them using a technique known as image-guided, multiprobe cryotherapy....

• New Way to Treat Inoperable Lung Cancer

An experimental type of highly focused radiation therapy may control inoperable lung cancer tumors and help people with the deadly disease live longer, a study shows....

• New Drug Shows Promise in Treating Ovarian Cancer

The experimental drug olaparib, which has been shown to be effective in treating ovarian cancer in patients with BRCA1 or BRCA2 gene mutations, also appears to work in some patients without the mutations....

• Drug May Help Fight Rare Pancreatic Cancer

Sutent -- a pill that cuts off the supply of nutrients to tumors -- shows promise for treating people with the rare type of pancreatic cancer that afflicted Apple CEO Steve Jobs....

• New Drug May Treat Advanced Melanoma

A new drug that fights tumors throughout the bodies of advanced melanoma patients points the way to powerful new treatments for many kinds of cancer....

• Tamoxifen May Cut Lung Cancer Deaths

Tamoxifen, the medication long used to prevent the growth of breast cancer tumors, also appears to reduce the risk of dying from lung cancer, research suggests....

• Avodart May Lower Prostate Cancer Risk

Avodart, a widely prescribed drug used to shrink enlarged prostates, appears to reduce the incidence of prostate cancer in men with an increased risk for the disease....

• Avodart May Lower Prostate Cancer Risk

Avodart, a widely prescribed drug used to shrink enlarged prostates, appears to reduce the incidence of prostate cancer in men with an increased risk for the disease....

• New Progress in Targeted Lung Cancer Therapy

New research offers hope that people with lung cancer will live longer if drug therapy is guided by the molecular traits of tumors....

• Low Vitamin D Levels for Skin Cancer Patients

Protecting your skin from the sun to help prevent skin cancer may have an unhealthy side effect: vitamin D deficiency....

• Breast Cancer Drug Eribulin Extends Survival

The new breast cancer drug eribulin (Halaven) extends survival two and a half months longer than other therapies for advanced breast cancer, researchers report....

• Lung Cancer Drug Crizotinib Shows Promise

An experimental drug is showing great promise as a targeted treatment for lung cancer patients with a specific genetic abnormality....

• IVF May Raise Risk for Less Aggressive Ovarian Cancer

Women who undergo ovarian stimulation as part of IVF (in vitro fertilization) treatment may be more likely to develop "borderline" ovarian tumors, but not invasive ovarian tumors, later in life, Dutch researchers report....

• Breast Cancer Drug Fights Lung Cancer, Too

The anti-hormone drug tamoxifen, which is used to treat breast cancer, may also reduce the risk of dying from lung cancer, a study of over 6,000 women suggests....

• Bone Drug Fails in Breast Cancer Study

The bone-building drug Zometa does not appear to prevent breast cancer from coming back in most women, researchers report....

• FDA Approves New Melanoma Treatment Yervoy

The FDA has approved Bristol-Myers' Yervoy for the treatment of late-stage, metastatic melanoma, a deadly skin cancer. The drug extends survival but does not cure the disease....

• Experimental MS Drug Outperforms Standard Treatment

Nearly 71% of people with early relapsing-remitting multiple sclerosis (MS) treated with the an experimental MS drug showed no evidence of disease activity four years into a study, researchers report....

• Sweat Gland Cancers Rare but on the Rise

Tumors of skin appendages such as cancer of the sweat gland, hair follicle, or sebaceous gland, although rare, appear to be increasing substantially in the U.S., a new study finds....

• Some IBD Drugs May Raise Skin Cancer Risk

Patients with inflammatory bowel disease or IBD may be at an increased risk for getting skin cancer, according to a study presented at the American College of Gastroenterology's annual meeting in San Diego....

• Sea Sponge Drug May Fight Breast Cancer

A drug derived from sea sponges extended the lives of breast cancer patients whose cancer had come back -- despite as many as five rounds of chemotherapy -- by an average of two and a half months....

• Sam Champion Spotlights Skin Cancer Awareness

His personal experience with skin cancer has led Good Morning America co-anchor Sam Champion to spotlight the disease....

• Sam Champion Spotlights Skin Cancer Awareness

His personal experience with skin cancer has led Good Morning America co-anchor Sam Champion to spotlight the disease....

• Experimental MS Drug Outperforms Standard Treatment

Nearly 71% of people with early relapsing-remitting multiple sclerosis (MS) treated with the an experimental MS drug showed no evidence of disease activity four years into a study, researchers report....

• Nexavar May Treat Advanced Breast Cancer

Adding the cancer drug Nexavar to standard chemotherapy significantly extends the time until advanced breast cancer progresses, researchers report....

• Many Patients with Incurable Brain Tumors Seek Complementary Therapies

Many people diagnosed with incurable brain tumors turn to complementary therapies to slow the growth of their cancer or relieve side effects like fatigue and depression, new research shows....